Financials

  • Market Capitalization 758.13 M
  • Employee 29
  • Founded 2018
  • CEO N/A
  • Website www.climbbio.com
  • Headquarter Delaware, United States
  • FIGI BBG00ZNKL0K6
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-4.55
ratio cours/chiffre d'affaires
-932.13

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
2638
RIGL
Rigel Pharmaceuticals, Inc. - Common Stock
41.17 USD-0.31%-0.17%+22.75%+36.64%761.73 M USD
2640
OMER
Omeros Corporation - Common Stock
10.50 USD+4.90%+2.14%+12.42%+189.26%759.94 M USD
2646
SPRY
ARS Pharmaceuticals, Inc. - Common Stock
7.61 USD-1.68%+0.13%-22.35%-17.37%755.70 M USD
2678
AURA
Aura Biosciences, Inc. - Common Stock
7.00 USD0.00%-0.43%+9.03%+6.71%723.71 M USD